Telomere length and brain imaging phenotypes in UK Biobank
Telomeres form protective caps at the ends of chromosomes, and their attrition is a marker of biological aging. Short telomeres are associated with an increased risk of neurological and psychiatric disorders including dementia. The mechanism underlying this risk is unclear, and may involve brain str...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Public Library of Science
2023
|
_version_ | 1826310157631488000 |
---|---|
author | Topiwala, A Nichols, TE Williams, LZJ Robinson, EC Alfaro-Almagro, F Taschler, B Wang, C Nelson, CP Miller, KL Codd, V Samani, NJ Smith, SM |
author_facet | Topiwala, A Nichols, TE Williams, LZJ Robinson, EC Alfaro-Almagro, F Taschler, B Wang, C Nelson, CP Miller, KL Codd, V Samani, NJ Smith, SM |
author_sort | Topiwala, A |
collection | OXFORD |
description | Telomeres form protective caps at the ends of chromosomes, and their attrition is a marker of biological aging. Short telomeres are associated with an increased risk of neurological and psychiatric disorders including dementia. The mechanism underlying this risk is unclear, and may involve brain structure and function. However, the relationship between telomere length and neuroimaging markers is poorly characterized. Here we show that leucocyte telomere length (LTL) is associated with multi-modal MRI phenotypes in 31,661 UK Biobank participants. Longer LTL is associated with: i) larger global and subcortical grey matter volumes including the hippocampus, ii) lower T1-weighted grey-white tissue contrast in sensory cortices, iii) white-matter microstructure measures in corpus callosum and association fibres, iv) lower volume of white matter hyperintensities, and v) lower basal ganglia iron. Longer LTL was protective against certain related clinical manifestations, namely all-cause dementia (HR 0.93, 95% CI: 0.91–0.96), but not stroke or Parkinson’s disease. LTL is associated with multiple MRI endophenotypes of neurodegenerative disease, suggesting a pathway by which longer LTL may confer protective against dementia. |
first_indexed | 2024-03-07T07:46:24Z |
format | Journal article |
id | oxford-uuid:0fd7e0bd-b905-4943-9d7e-582c09bfd883 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T07:46:24Z |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | dspace |
spelling | oxford-uuid:0fd7e0bd-b905-4943-9d7e-582c09bfd8832023-06-19T15:53:53ZTelomere length and brain imaging phenotypes in UK BiobankJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0fd7e0bd-b905-4943-9d7e-582c09bfd883EnglishSymplectic ElementsPublic Library of Science2023Topiwala, ANichols, TEWilliams, LZJRobinson, ECAlfaro-Almagro, FTaschler, BWang, CNelson, CPMiller, KLCodd, VSamani, NJSmith, SMTelomeres form protective caps at the ends of chromosomes, and their attrition is a marker of biological aging. Short telomeres are associated with an increased risk of neurological and psychiatric disorders including dementia. The mechanism underlying this risk is unclear, and may involve brain structure and function. However, the relationship between telomere length and neuroimaging markers is poorly characterized. Here we show that leucocyte telomere length (LTL) is associated with multi-modal MRI phenotypes in 31,661 UK Biobank participants. Longer LTL is associated with: i) larger global and subcortical grey matter volumes including the hippocampus, ii) lower T1-weighted grey-white tissue contrast in sensory cortices, iii) white-matter microstructure measures in corpus callosum and association fibres, iv) lower volume of white matter hyperintensities, and v) lower basal ganglia iron. Longer LTL was protective against certain related clinical manifestations, namely all-cause dementia (HR 0.93, 95% CI: 0.91–0.96), but not stroke or Parkinson’s disease. LTL is associated with multiple MRI endophenotypes of neurodegenerative disease, suggesting a pathway by which longer LTL may confer protective against dementia. |
spellingShingle | Topiwala, A Nichols, TE Williams, LZJ Robinson, EC Alfaro-Almagro, F Taschler, B Wang, C Nelson, CP Miller, KL Codd, V Samani, NJ Smith, SM Telomere length and brain imaging phenotypes in UK Biobank |
title | Telomere length and brain imaging phenotypes in UK Biobank |
title_full | Telomere length and brain imaging phenotypes in UK Biobank |
title_fullStr | Telomere length and brain imaging phenotypes in UK Biobank |
title_full_unstemmed | Telomere length and brain imaging phenotypes in UK Biobank |
title_short | Telomere length and brain imaging phenotypes in UK Biobank |
title_sort | telomere length and brain imaging phenotypes in uk biobank |
work_keys_str_mv | AT topiwalaa telomerelengthandbrainimagingphenotypesinukbiobank AT nicholste telomerelengthandbrainimagingphenotypesinukbiobank AT williamslzj telomerelengthandbrainimagingphenotypesinukbiobank AT robinsonec telomerelengthandbrainimagingphenotypesinukbiobank AT alfaroalmagrof telomerelengthandbrainimagingphenotypesinukbiobank AT taschlerb telomerelengthandbrainimagingphenotypesinukbiobank AT wangc telomerelengthandbrainimagingphenotypesinukbiobank AT nelsoncp telomerelengthandbrainimagingphenotypesinukbiobank AT millerkl telomerelengthandbrainimagingphenotypesinukbiobank AT coddv telomerelengthandbrainimagingphenotypesinukbiobank AT samaninj telomerelengthandbrainimagingphenotypesinukbiobank AT smithsm telomerelengthandbrainimagingphenotypesinukbiobank |